Nevada Biotechnology & Bioscienceconsortium
EIN: 260681229 · Las Vegas, NV · NTEE: U035
| Metric | Value |
|---|---|
| Total Revenue | $146K |
| Total Expenses | $91K |
| Net Assets | $415K |
Search Intent Cockpit
Nevada Biotechnology & Bioscienceconsortium Form 990, Revenue, CEO Pay, and IRS Filing Signals
Nevada Biotechnology & Bioscienceconsortium is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Nevada Biotechnology & Bioscienceconsortium in one place.
Form 990 Filing Summary
13 filing years are available, with latest revenue of $146K and expenses of $91K.
Revenue and Expenses
Nevada Biotechnology & Bioscienceconsortium reported $146K in revenue and $91K in expenses, a surplus of $55K.
Executive Compensation
Officer, director, trustee, and key employee pay is reviewed from IRS 990 compensation disclosures when present.
Charity Score and Red Flags
Mission score and red-flag review are shown when AI enrichment is available.
Is Nevada Biotechnology & Bioscienceconsortium Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
Functional expense detail is not available on the stored filing yet. Existing program percentage and future extracted expense fields will populate this panel.
Across stored filings, Nevada Biotechnology & Bioscienceconsortium shows contribution history pending. Next enrichment targets: revenue-source fields, functional expense detail, IRS BMF classification, AI synthesis.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Insufficient Data | Good filing record; no red flags identified |
| Mission spend | Pending | Unknown |
| Financial durability | Grade A | 13 stored filing years |
| Peer context | Compare with Tortie Foundation | Nevada and Category U context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with Tortie Foundation →All Nevada nonprofits
All Category U
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
Las Vegas, NV nonprofitsCategory U in Nevada
Public Benefit in Nevada
Follow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Category U spending
Best Category U charities in Nevada
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Alternative Shopping
Similar Nonprofits Donors Should Compare
Mgm Resorts Foundation
Las Vegas, NV · $5.1M revenue · Score 92/100
Compare side-by-sideGovernment Investment Officers Association
Las Vegas, NV · $465K revenue · Score 85/100
Compare side-by-sideWinnemucca Regional Raceway Association
Winnemucca, NV · $162K revenue · Score 85/100
Compare side-by-sideEaa Chapter 1361 Inc
Reno, NV · $0 revenue · Score 60/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
About Nevada Biotechnology & Bioscienceconsortium
Nevada Biotechnology & Bioscienceconsortium (EIN: 260681229) is a nonprofit organization based in Las Vegas, NV, classified under NTEE code U035. The organization reported total revenue of $146K and total assets of $430K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Nevada Biotechnology & Bioscienceconsortium's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Nevada Biotechnology & Bioscienceconsortium is a small nonprofit that has been operating for 15 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 24.3%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $146K |
| Total Expenses | $91K |
| Surplus / Deficit | +$55K |
| Total Assets | $430K |
| Total Liabilities | $16K |
| Net Assets | $415K |
| Operating Margin | 37.4% |
| Debt-to-Asset Ratio | 3.6% |
| Months of Reserves | 56.5 months |
Financial Health Grade: A
In 2023, Nevada Biotechnology & Bioscienceconsortium reported a surplus of $55K with revenue exceeding expenses, holds 56.5 months of operating reserves (strong position), has a debt-to-asset ratio of 3.6% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Nevada Biotechnology & Bioscienceconsortium's revenue has grown at a compound annual growth rate (CAGR) of 24.3%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -13.5% | -10.1% | +14.5% |
| 2022 | +4.6% | +17.6% | +21.7% |
| 2021 | +10.5% | +11.5% | +32.0% |
| 2020 | -6.1% | -22.8% | +41.4% |
| 2019 | +0.0% | -5.3% | +49.7% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2011 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Nevada Biotechnology & Bioscienceconsortium has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Nevada Biotechnology & Bioscienceconsortium with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $55K, with revenue exceeding expenses.
- Debt-to-asset ratio: 3.6%.
Frequently Asked Questions about Nevada Biotechnology & Bioscienceconsortium
Is Nevada Biotechnology & Bioscienceconsortium a legitimate charity?
Nevada Biotechnology & Bioscienceconsortium (EIN: 260681229) is a registered tax-exempt nonprofit based in Nevada. It has 13 years of IRS 990 filings on record. Total revenue: $146K. No red flags identified. Financial health grade: A.
How does Nevada Biotechnology & Bioscienceconsortium spend its money?
Nevada Biotechnology & Bioscienceconsortium reported $146K in total revenue in IRS 990 filings. 13 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Nevada Biotechnology & Bioscienceconsortium tax-deductible?
Nevada Biotechnology & Bioscienceconsortium is registered as a tax-exempt nonprofit (EIN: 260681229). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Nevada Biotechnology & Bioscienceconsortium located?
Nevada Biotechnology & Bioscienceconsortium is headquartered in Las Vegas, Nevada and files with the IRS under EIN 260681229. It is classified under NTEE code U035.
How many years of IRS 990 filings does Nevada Biotechnology & Bioscienceconsortium have?
Nevada Biotechnology & Bioscienceconsortium has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $146K in total revenue.
Filing History
IRS 990 filing history for Nevada Biotechnology & Bioscienceconsortium showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Nevada Biotechnology & Bioscienceconsortium's revenue has grown by 1259.5%, moving from $11K to $146K. Total assets increased by 10718.6% over the same period, from $4K to $430K. Total functional expenses rose by 569.6%, from $14K to $91K. In its most recent filing year (2023), Nevada Biotechnology & Bioscienceconsortium reported a surplus of $55K, with revenue exceeding expenses. The organization holds $16K in liabilities against $430K in assets (debt-to-asset ratio: 3.6%), resulting in net assets of $415K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $146K | $91K | $430K | $16K | — | — |
| 2022 | $169K | $102K | $376K | $16K | — | View 990 |
| 2021 | $161K | $86K | $308K | $16K | — | View 990 |
| 2020 | $146K | $78K | $234K | $16K | — | View 990 |
| 2019 | $155K | $100K | $165K | $16K | — | View 990 |
| 2018 | $155K | $106K | $110K | $16K | — | View 990 |
| 2017 | $102K | $81K | $61K | $16K | — | View 990 |
| 2016 | $70K | $52K | $40K | $16K | — | View 990 |
| 2015 | $94K | $73K | $22K | $16K | — | View 990 |
| 2014 | $42K | $42K | $1K | $16K | — | View 990 |
| 2013 | $9K | $12K | $763 | $16K | — | View 990 |
| 2012 | $12K | $18K | $4K | $16K | — | View 990 |
| 2011 | $11K | $14K | $4K | $10K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $146K, expenses of $91K, and assets of $430K (revenue -13.5% year-over-year).
- 2022: Revenue of $169K, expenses of $102K, and assets of $376K (revenue +4.6% year-over-year).
- 2021: Revenue of $161K, expenses of $86K, and assets of $308K (revenue +10.5% year-over-year).
- 2020: Revenue of $146K, expenses of $78K, and assets of $234K (revenue -6.1% year-over-year).
- 2019: Revenue of $155K, expenses of $100K, and assets of $165K (revenue +0.0% year-over-year).
- 2018: Revenue of $155K, expenses of $106K, and assets of $110K (revenue +52.0% year-over-year).
- 2017: Revenue of $102K, expenses of $81K, and assets of $61K (revenue +47.0% year-over-year).
- 2016: Revenue of $70K, expenses of $52K, and assets of $40K (revenue -26.0% year-over-year).
- 2015: Revenue of $94K, expenses of $73K, and assets of $22K (revenue +121.9% year-over-year).
- 2014: Revenue of $42K, expenses of $42K, and assets of $1K (revenue +388.1% year-over-year).
- 2013: Revenue of $9K, expenses of $12K, and assets of $763 (revenue -25.9% year-over-year).
- 2012: Revenue of $12K, expenses of $18K, and assets of $4K (revenue +9.0% year-over-year).
- 2011: Revenue of $11K, expenses of $14K, and assets of $4K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Nevada Biotechnology & Bioscienceconsortium:
Data Sources and Methodology
This transparency report for Nevada Biotechnology & Bioscienceconsortium is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.